Usa hospital covid-19 Ventilators patient Usa

5 days of remdesivir for COVID-19 may be enough

Reading now: 133
www.cidrap.umn.edu

Results from an ongoing phase 3 study published yesterday in the New England Journal of Medicine showed no significant difference in the clinical status of hospitalized COVID-19 patients not requiring mechanical ventilation after a 5-day course of the antiviral drug remdesivir compared with patients who had a 10-day course.But the randomized, open-label trial lacked a placebo control, so the degree of benefit could not be determined.Sponsored by remdesivir maker Gilead, the trial took place at 55 hospitals in the United States, Asia, and Europe from Mar 6 to 26.

Investigators randomly assigned 397 coronavirus patients with an oxygen saturation of 94% or less and radiologic evidence of pneumonia to receive intravenous remdesivir, with a

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA